10X Genomics, Inc. (TXG)
68.59
+2.21
(+3.33%)
USD |
NASDAQ |
Sep 11, 16:00
67.63
-0.96
(-1.40%)
After-Hours: 05:35
10X Genomics Enterprise Value : 8.463B for Sept. 11, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 8.463B |
| September 10, 2026 | 8.175B |
| September 09, 2026 | 8.293B |
| September 08, 2026 | 8.073B |
| September 04, 2026 | 7.689B |
| September 03, 2026 | 7.763B |
| September 02, 2026 | 7.559B |
| September 01, 2026 | 7.341B |
| August 31, 2026 | 7.663B |
| August 28, 2026 | 7.544B |
| August 27, 2026 | 7.976B |
| August 26, 2026 | 7.899B |
| August 25, 2026 | 7.959B |
| August 24, 2026 | 7.839B |
| August 21, 2026 | 8.011B |
| August 20, 2026 | 7.848B |
| August 19, 2026 | 7.629B |
| August 18, 2026 | 6.774B |
| August 17, 2026 | 7.082B |
| August 14, 2026 | 6.834B |
| August 13, 2026 | 7.103B |
| August 12, 2026 | 7.051B |
| August 11, 2026 | 7.146B |
| August 10, 2026 | 7.157B |
| August 07, 2026 | 6.305B |
| Date | Value |
|---|---|
| August 06, 2026 | 5.468B |
| August 05, 2026 | 5.710B |
| August 04, 2026 | 5.762B |
| August 03, 2026 | 5.651B |
| July 31, 2026 | 5.685B |
| July 30, 2026 | 5.967B |
| July 29, 2026 | 5.561B |
| July 28, 2026 | 5.657B |
| July 27, 2026 | 5.509B |
| July 24, 2026 | 5.555B |
| July 23, 2026 | 5.788B |
| July 22, 2026 | 5.657B |
| July 21, 2026 | 5.676B |
| July 20, 2026 | 5.158B |
| July 17, 2026 | 5.225B |
| July 16, 2026 | 5.322B |
| July 15, 2026 | 5.487B |
| July 14, 2026 | 5.492B |
| July 13, 2026 | 4.969B |
| July 10, 2026 | 5.094B |
| July 09, 2026 | 5.142B |
| July 08, 2026 | 4.408B |
| July 07, 2026 | 4.455B |
| July 06, 2026 | 4.738B |
| July 02, 2026 | 4.609B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Twist Bioscience Corp. | 7.900B |
| Personalis, Inc. | 1.550B |
| Alamar Biosciences, Inc. (California) | 1.737B |
| Tempus AI, Inc. | 11.25B |
| Adaptive Biotechnologies Corp. | 3.923B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -17.93M |
| Revenue (Quarterly) | 151.04M |
| Total Expenses (Quarterly) | 168.97M |
| EPS Diluted (Quarterly) | -0.138 |
| Gross Profit Margin (Quarterly) | 74.36% |
| Profit Margin (Quarterly) | -11.87% |
| Earnings Yield | -0.86% |
| Normalized Earnings Yield | -0.877 |